Trial Profile
A Randomized, Open Label Comparative Study of Irbesartan/Hydrochlorothiazide and Irbesartan in the Treatment of Mild to Moderate Hypertension.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 16 Jul 2009
Price :
$35
*
At a glance
- Drugs Irbesartan/hydrochlorothiazide (Primary) ; Irbesartan
- Indications Hypertension
- Focus Therapeutic Use
- Sponsors Sanofi
- 18 Sep 2006 New trial record.